M&A Deal Summary

Envision Pharma Acquires Two Labs

On November 12, 2020, Envision Pharma acquired life science company Two Labs from Excellere Partners

Acquisition Highlights
  • This is Envision Pharma’s 1st transaction in the Life Science sector.
  • This is Envision Pharma’s 2nd transaction in the United States.
  • This is Envision Pharma’s 1st transaction in Ohio.

M&A Deal Summary
Date 2020-11-12
Target Two Labs
Sector Life Science
Buyer(s) Envision Pharma
Sellers(s) Excellere Partners
Deal Type Add-on Acquisition

Target

Two Labs

Powell, Ohio, United States
Two Labs LLC is a pharmaceutical services company that provides a portfolio of product commercialization and lifecycle services to pharmaceutical manufacturers. Since its inception in 2003, Two Labs has worked with over 380 manufacturers. This includes supporting over 150 emerging manufacturers with their first product and over 230 pharmaceutical manufacturers with in-market products from pre-launch to loss of exclusivity.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Envision Pharma

Horsham, United Kingdom
Category Company
Founded 2001
Sector Information Technology
DESCRIPTION

Envision Pharma is a global technology and scientific communication company serving the pharmaceutical, biotechnology, and medical device companies. Envision has grown steadily under consistent leadership across its three core business areas that include scientific solutions – strategic publication planning and related data dissemination services, technology Solutions – design, development, implementation, and support of innovative and strategic management software for life sciences clients including publication planning and management (DatavisionTM), clearance approval (dvClear), and activity request management (Visiontracker) and professional consulting solutions policy, process, compliance and guideline consultancy to life-science companies. Envision Pharma was founded in 2001 and is based in Horsham, United Kingdom.

DEAL STATS #
Overall 4 of 5
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 4 of 5
State (Ohio) 1 of 1
Country (United States) 2 of 3
Year (2020) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-08 90TEN Group

London, United Kingdom

90TEN Group Ltd. is an independent healthcare communications consultancy that specialises in using proven behavioural change tools to maximise brand and health outcomes. The company delivers highly creative, award-winning global and international public relations, medical education and patient engagement programmes for pharmaceutical and healthcare clients. 90TEN Group was formed in 2001 and is based in London.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-22 doDOC

Boston, Massachusetts, United States

doDOC is a Software as a Service (SaaS)-based platform that enables simultaneous collaboration in the review, editing, and authoring of documents among multiple users. Designed for the pharma and life sciences industries, it offers significant industry-specific advantages over general document authoring solutions in the market today. doDOC was founded in 2015 and is based in Boston, Massachusetts.

Buy -

Seller(S) 1

SELLER

Excellere Partners

Denver, Colorado, United States
Category Private Equity Firm
Founded 2006
PE ASSETS 2.3B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Excellere Partners is a private equity firm focused on mid-market recapitalizations, management buyouts, and consolidation opportunities. Excellere looks to partner with management on transactions and targets opportunities in business services, education/training, healthcare, industrial services, and specialty foods. Excellere Partners was formed in 2006 and is based in Denver, Colorado.

DEAL STATS #
Overall 9 of 12
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 4 of 5
State (Ohio) 1 of 1
Country (United States) 9 of 12
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-01 ADVENT

Milwaukee, Wisconsin, United States

ADVENT is a provider of otolaryngology (“ENT”) services in Illinois and Wisconsin, seeking to improve patient outcomes by identifying, diagnosing, and treating the root causes of breathing and sleeping issues. ADVENT was founded in 2004 and is based in Milwaukee, Wisconsin.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-21 SCA Pharma

Little Rock, Arkansas, United States

SCA Pharma specializes in preparing sterile pharmaceuticals customized for hospital pharmacies and healthcare facilities nationwide. SCA Pharmaceuticals products and services have consistently proven to significantly increase efficiencies and reduce costs to these organizations. SCA Pharma was founded in 2010 and is based in Little Rock, Arkansas.

Buy -
Mergr

Product

Company

Legal